General MedicationsINTRAVENOUSStandard

FOSCARNET SODIUM

Standard Dose

6GM/250ML (24MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview FOSCARNET SODIUM is listed in Drugs@FDA under application 216602 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FOSCARNET SODIUM Form and strength SOLUTION;INTRAVENOUS - 6GM/250ML (24MG/ML) Sponsor AMNEAL Submission history Latest submission status date: 2024-03-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview FOSCARNET SODIUM is listed in Drugs@FDA under application 216602 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FOSCARNET SODIUM Form and strength SOLUTION;INTRAVENOUS - 6GM/250ML (24MG/ML) Sponsor AMNEAL Submission history Latest submission status date: 2024-03-01 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.